| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| onc201 | dopamine d2 receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] Endometrial Carcinoma[MeSHID:D016889] Lymphoma[MeSHID:D008223] Carcinoma Neuroendocrine[MeSHID:D018278] leukemia[MeSHID:D007938] Glioma[MeSHID:D005910] Malignant Neoplasms[MeSHID:D009369] Respiratory Tract Infections[MeSHID:D012141] |
0.07 | phase 2 | unknown |
| onc201 | dopamine d3 receptor | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Multiple Myeloma[MeSHID:D009101] Endometrial Carcinoma[MeSHID:D016889] Lymphoma[MeSHID:D008223] Carcinoma Neuroendocrine[MeSHID:D018278] leukemia[MeSHID:D007938] Glioma[MeSHID:D005910] Malignant Neoplasms[MeSHID:D009369] Respiratory Tract Infections[MeSHID:D012141] |
0.15 | phase 2 | unknown |
| click here to return to the previous page | ||||||||